Aarti Drugs fell 2.24% to Rs 552.65, extending decline for second day.
The stock has lost 4.44% in two sessions, from its recent closing high of Rs 578.35 recorded on 13 December 2021.
The scrip is currently trading 34.32% lower from its 52-week high of Rs 841.40 hit on 14 May 2021. It has gained 12.52% from its 52-week low of Rs 491.15 hit on 23 November 2021.
In the past one year, the stock has declined 28.92% while the benchmark Sensex has added 24.86% during the same period.
On the technical front, the stock's RSI (relative strength index) stood at 52.018. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.
The stock was trading above its 50-day, 100-day and 200-day moving average (DMA) placed at 571.89, 603.68 and 661.32, respectively.
Aarti Industries is a manufacturer of specialty chemicals and pharmaceuticals.
The company's consolidated net profit declined 43.42% to Rs 42.59 crore as net sales remained flat at Rs 579.62 crore in Q2 FY22 over Q2 FY21.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
